MERIT Celebrates 7th Consecutive INC 5000 Listing

August 13, 2024 09:30 PM AEST | By EIN Presswire

Google News:

MERIT Celebrates 7th Consecutive INC 5000 Listing — Image source: EIN Presswire

Recent News

Fed Daly eyes fall for possible policy shift

Fifth Third Announces Three-Year, $20M Investment in North Nashville

Inogen Alliance Associate Awards: Environment Analyst Sustainability D...

New Zealand Construction Report 2025: Output to Contract by 1% Due to...

MADISON, WI, UNITED STATES, August 13, 2024 /EINPresswire.com/ -- MERIT CRO, Inc., a global endpoint service and technology provider specializing in multiple therapeutic areas, announced today that it has been named to the Inc. 5000 list of fastest-growing private companies for the seventh year in a row. MERIT received the rank of 3232 for the 2024 list.

“For MERIT to be ranked on the Inc. 5000 for a seventh-year running is a remarkable achievement,” said Yijun Huang, Co-Founder and CEO of MERIT. “This honor is a direct result of both the hard work of our entire team as well as our commitment to delivering innovation to our clients through our proprietary EXCELSIOR™ technology platform,” he added.

ABOUT MERIT
MERIT is an innovative, global clinical trial endpoint and technology services provider working in a variety of therapeutic areas, including ophthalmology, respiratory, oncology, cardiac safety, dermatology, and neurology. We partner with CROs as well as pharmaceutical and biotech companies to deliver reliable endpoint services in multi-regional clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide.
MERIT’s offices are in Madison, WI, North Liberty, IA, and Shanghai, China. We have a proven track record of providing endpoint expertise to 13 of the top 20 global pharmaceutical companies, supporting sites in 62 countries around the world. Learn more at https://meritcro.com/

ABOUT EXCELSIOR
MERIT’s comprehensive, cloud-based software solution elevates efficiency and accuracy in the collection and interpretation of clinical trial imaging data. Client benefits of EXCELSIOR include 24/7 data access, immediate data transfer, and no geographic limitations. EXCELSIOR is built to meet regulatory requirements including HIPAA, 21 CFR Part 11, GDPR, and HGRAC.

INC 5000 METHODOLOGY
The Inc. 5000 list of the fastest-growing privately held companies is considered by many to be a top hallmark of entrepreneurial success. The Inc. 5000 ranks companies by overall revenue growth over a three-year period. Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent -- not subsidiaries or divisions of other companies.

Stacy Sanderson
MERIT
+1 608-284-8810
email us here
Visit us on social media:
X
LinkedIn
YouTube

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.